Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EHAB
EHAB logo

EHAB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Enhabit Inc (EHAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.750
1 Day change
0.07%
52 Week Range
14.220
Analysis Updated At
2026/05/01
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

EHAB is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is effectively capped near the Kinderhook all-cash deal price of $13.80, leaving very limited upside from the current price of $13.73. With no AI Stock Picker signal, no SwingMax signal, neutral insider and hedge fund activity, and technicals showing weak momentum, the better choice is to hold rather than buy at this level.

Technical Analysis

The current price is 13.73, essentially flat to the previous close and sitting right below the merger value. MACD histogram is negative at -0.0469, though contracting, which still points to weak momentum rather than a fresh uptrend. RSI_6 at 35.121 is neutral-to-soft, and moving averages are converging, suggesting indecision rather than strength. Price is trading tightly around pivot 13.738 with resistance at 13.769 and 13.788, while support sits at 13.708 and 13.689. The stock trend model also indicates downside bias, with a 70% chance of -1.75% next day, -0.91% next week, and -6.03% next month.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is mildly bearish/defensive based on the 1.1 open interest put-call ratio, meaning puts slightly exceed calls. However, option volume is effectively zero, so there is no active trading conviction in the options market. Elevated implied volatility at 80.44 and IV percentile of 90.44 reflect event-driven pricing around the acquisition, not strong bullish demand.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
11

Positive Catalysts

  • ["Enhabit agreed to be acquired by Kinderhook Industries in an all-cash transaction at $13.80 per share, providing a clear deal value floor.", "Revenue in 2025/Q4 increased 4.73% year over year, showing modest top-line growth.", "Gross margin improved to 46.86%, up 3.24% year over year."]

Neutral/Negative Catalysts

  • ["Current price of 13.73 is only about 0.07 below the deal price, leaving almost no upside for a new buyer.", "Jefferies downgraded the stock to Hold from Buy after the acquisition announcement.", "Net income fell to -38.7 million and EPS dropped to -0.76 in 2025/Q4, indicating weak profitability.", "Technical momentum is weak: negative MACD, soft RSI, and a downside-biased short-term pattern forecast.", "Hedge funds and insiders are both neutral, with no significant recent buying activity.", "No AI Stock Picker signal and no SwingMax signal are present today."]

Financial Performance

In 2025/Q4, Enhabit posted revenue of 270.4 million, up 4.73% year over year, which is a positive growth trend. But profitability remains weak, with net income declining to -38.7 million and EPS falling to -0.76, both down meaningfully year over year. Gross margin improved to 46.86%, which is a constructive sign, but the quarter still shows a business with improving revenue and margins while remaining unprofitable.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst action turned less favorable: Jefferies downgraded EHAB to Hold from Buy while raising the target to $13.80, essentially matching the Kinderhook acquisition price. That implies Wall Street sees the stock as fairly valued at the deal value rather than an attractive standalone buy. The pros view is that the acquisition locks in value and limits downside. The cons view is that upside is capped, and recent analyst tone reflects that there is little remaining appreciation potential.

Wall Street analysts forecast EHAB stock price to fall
5 Analyst Rating
Wall Street analysts forecast EHAB stock price to fall
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.740
sliders
Low
10.5
Averages
12.2
High
14
Current: 13.740
sliders
Low
10.5
Averages
12.2
High
14
Jefferies
Buy
to
Hold
downgrade
AI Analysis
2026-02-23
Reason
Jefferies
Price Target
AI Analysis
2026-02-23
downgrade
Buy
to
Hold
Reason
Jefferies downgraded Enhabit to Hold from Buy with a price target of $13.80, up from $12.50, following the company's agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share.
Oppenheimer
Perform
to
Outperform
upgrade
$14
2026-01-22
Reason
Oppenheimer
Price Target
$14
2026-01-22
upgrade
Perform
to
Outperform
Reason
Oppenheimer upgraded Enhabit to Outperform from Perform with a $14 price target. The firm believes the post-acute care group is benefiting from "major tailwinds," including strong demand, a more stable regulatory environment, and improving labor trends. Enhabit is positioned to benefit from an improved reimbursement outlook, the analyst tells investors in a research note. In addition, Oppenheimer says the company's operational initiatives should drive the business going forward.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EHAB
Unlock Now

People Also Watch